| Gastrointestinal
Oncology Research Program
The
Gastrointestinal Oncology Center at Loyola University
Health System is a key program of the Cardinal
Bernardin Cancer Center and the Loyola University
Chicago Stritch School of Medicine Oncology
Institute. Clinical research physicians and
basic scientists work in close collaboration to
develop innovative treatments for gastrointestinal
(GI) cancer patients.
“Translational research” defines the
program’s philosophy. Translational research
transforms cellular, genetic and molecular discoveries
into actual tools for patient care. These tools
may encompass disease treatment, diagnosis and
prevention. In contrast to traditional research,
which focuses on proving a hypothesis or treating
a symptom, translational research connects the
lab, clinic and community findings. With new approaches,
the complex infrastructure of translational research
bridges the “silos” of traditional
medicine. The result is improved patient care.
Loyola's
gastrointestinal oncology team works to provide
promising clinical research studies for our patients.
Together, our team is making progress in treating
GI cancers.
Most
significant is study of a vaccine treatment to
fight pancreatic cancer. A patient's own immune
cells are harvested and increased in the laboratory.
They are then injected back into the patient to
aid the immune system in fighting the cancer.
At
Loyola, these bedside-to-bench-to-bedside collaborations
are key for a meaningful and successful research
program.
Related
Links
Clinical
trials
Loyola
CAN-HELP Cancer Information and Referral
|
